Detalhe da pesquisa
1.
Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results.
PLoS One
; 18(7): e0288271, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37467213
2.
Safety, tolerability, pharmacokinetics, and pharmacodynamics of oral JNJ-64794964, a TLR-7 agonist, in healthy adults.
Antivir Ther
; 26(3-5): 58-68, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35485332
3.
Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid Tumors.
Mol Cancer Ther
; 17(1): 215-221, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29054986